医院获得性菌血症和真菌血症的可预防性：一种潜在的医疗保健相关性感染结局测量方法的初步研究。
Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure.
机构信息
Division of Hospital Medicine, Department of Medicine,Emory University School of Medicine,Atlanta, Georgia.
Division of Infectious Diseases, Department of Medicine,Johns Hopkins University School of Medicine,Baltimore, Maryland.
出版信息
Infect Control Hosp Epidemiol. 2019 Mar;40(3):358-361. doi: 10.1017/ice.2018.339. Epub 2019 Feb 18.
Abstract
Hospital-onset bacteremia and fungemia (HOB), a potential measure of healthcare-associated infections, was evaluated in a pilot study among 60 patients across 3 hospitals. Two-thirds of all HOB events and half of nonskin commensal HOB events were judged as potentially preventable. Follow-up studies are needed to further develop this measure.
摘要
医院获得性菌血症和真菌血症（HOB），是一种潜在的医疗保健相关感染的衡量指标，在 3 家医院的 60 名患者中进行了试点研究。所有 HOB 事件的三分之二和非皮肤共生 HOB 事件的一半被认为是可以预防的。需要进一步开展随访研究来进一步完善这一措施。
相似文献
1
Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure.
Infect Control Hosp Epidemiol. 2019 Mar;40(3):358-361. doi: 10.1017/ice.2018.339. Epub 2019 Feb 18.
2
Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India.
Infect Control Hosp Epidemiol. 2024 Feb;45(2):157-166. doi: 10.1017/ice.2023.170. Epub 2023 Aug 18.
3
Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric.
Infect Control Hosp Epidemiol. 2019 May;40(5):536-540. doi: 10.1017/ice.2019.40. Epub 2019 Apr 1.
4
Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study.
BMJ Qual Saf. 2024 Jul 22;33(8):487-498. doi: 10.1136/bmjqs-2023-016831.
5
RE: Preventability of hospital onset bacterermia and fungemia: A pilot study of potential healthcare-associated infection outcome measure, by Dantes et al (2019).
Infect Control Hosp Epidemiol. 2019 Oct;40(10):1209-1210. doi: 10.1017/ice.2019.193. Epub 2019 Jul 25.
6
Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemia.
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1326-1332. doi: 10.1017/ice.2021.528. Epub 2022 Jan 28.
7
Prevention of Vascular Access Device-Associated Hospital-Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects.
Clin Infect Dis. 2025 Feb 24;80(2):444-450. doi: 10.1093/cid/ciae245.
8
Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.
Infect Control Hosp Epidemiol. 2023 Dec;44(12):1920-1926. doi: 10.1017/ice.2023.132. Epub 2023 Jul 10.
9
Catheter-associated urinary tract infections (CAUTIs) and non-CAUTI hospital-onset urinary tract infections: Relative burden, cost, outcomes and related hospital-onset bacteremia and fungemia infections.
Infect Control Hosp Epidemiol. 2024 Jul;45(7):864-871. doi: 10.1017/ice.2024.26. Epub 2024 Feb 20.
10
Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals.
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1317-1325. doi: 10.1017/ice.2022.211. Epub 2022 Sep 9.
引用本文的文献
1
Integrating Nonindividual Patient Features in Machine Learning Models of Hospital-Onset Bacteremia.
JAMA Netw Open. 2025 Jul 1;8(7):e2518815. doi: 10.1001/jamanetworkopen.2025.18815.
2
Hospital-onset bacteraemia and fungaemia as a novel automated surveillance indicator: results from four European university hospitals, 2018 to 2022.
Euro Surveill. 2025 Jun;30(24). doi: 10.2807/1560-7917.ES.2025.30.24.2400613.
3
Automated surveillance of hospital-onset bacteremia and fungemia: feasibility and epidemiological results from a Dutch multicenter study.
Infect Control Hosp Epidemiol. 2025 Feb 26;46(5):1-9. doi: 10.1017/ice.2025.29.
4
Hospital-onset bacteremia in the neonatal intensive care unit: strategies for risk adjustment.
Infect Control Hosp Epidemiol. 2025 Feb 17;46(4):1-7. doi: 10.1017/ice.2024.238.
5
Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study.
BMJ Qual Saf. 2024 Jul 22;33(8):487-498. doi: 10.1136/bmjqs-2023-016831.
6
Strengthening hospital epidemiology & infection prevention research capacity in India to curb antimicrobial resistance.
Indian J Med Res. 2024 Jan 1;159(1):7-9. doi: 10.4103/ijmr.ijmr_1919_23. Epub 2024 Mar 4.
7
Diagnostic stewardship to improve patient outcomes and healthcare-associated infection (HAI) metrics.
Infect Control Hosp Epidemiol. 2024 Apr;45(4):405-411. doi: 10.1017/ice.2023.284. Epub 2024 Jan 11.
8
Healthcare-associated infections and conditions in the era of digital measurement.
Infect Control Hosp Epidemiol. 2024 Jan;45(1):3-8. doi: 10.1017/ice.2023.139. Epub 2023 Sep 25.
9
Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India.
Infect Control Hosp Epidemiol. 2024 Feb;45(2):157-166. doi: 10.1017/ice.2023.170. Epub 2023 Aug 18.
10
Prevalence of Hospital-Onset Bacteremia Pre- and Post-Implementation of a Needleless Blood Sampling Device From Existing Peripheral Catheters.
J Infus Nurs. 2023;46(6):332-337. doi: 10.1097/NAN.0000000000000513. Epub 2023 Jul 24.
本文引用的文献
1
Culture if spikes? Indications and yield of blood cultures in hospitalized medical patients.
J Hosp Med. 2016 May;11(5):336-40. doi: 10.1002/jhm.2541. Epub 2016 Jan 13.
2
A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure?
Infect Control Hosp Epidemiol. 2016 Feb;37(2):143-8. doi: 10.1017/ice.2015.261. Epub 2015 Oct 23.
3
Comparison of total hospital-acquired bloodstream infections to central line-associated bloodstream infections and implications for outcome measures in infection control.
Infect Control Hosp Epidemiol. 2013 Sep;34(9):984-6. doi: 10.1086/671730. Epub 2013 Jul 25.
4
Clinical and economic impact of contaminated blood cultures within the hospital setting.
J Hosp Infect. 2011 Mar;77(3):233-6. doi: 10.1016/j.jhin.2010.09.033. Epub 2011 Jan 7.
5
Guidelines on blood cultures.
J Microbiol Immunol Infect. 2010 Aug;43(4):347-9. doi: 10.1016/S1684-1182(10)60054-0.
6
An intervention to decrease catheter-related bloodstream infections in the ICU.
N Engl J Med. 2006 Dec 28;355(26):2725-32. doi: 10.1056/NEJMoa061115.
7
Financial and clinical impact of false-positive blood culture results.
Clin Infect Dis. 2001 Aug 1;33(3):296-9. doi: 10.1086/321881. Epub 2001 Jun 21.
8
Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.
Bone Marrow Transplant. 2000 Jun;25(12):1269-78. doi: 10.1038/sj.bmt.1702447.
Zotero 插件